Multi-Composite Bioactive Osteogenic Sponges Featuring Mesenchymal Stem Cells, Platelet-Rich Plasma, Nanoporous Silicon Enclosures, and Peptide Amphiphiles for Rapid Bone Regeneration
Source abstract
Abstract
A novel bioactive sponge was created with a composite of type I collagen sponges or porous poly(e-caprolactone) (PCL) scaffolds, platelet-rich plasma (PRP), BMP2-loaded nanoporous silicon enclosure (NSE) microparticles, mineralizing peptide amphiphiles (PA), and mesenchymal stem cells (MSC). Primary MSC from cortical bone (CB) tissue proved to form more and larger colony units, as well as produce more mineral matrix under osteogenic differentiation, than MSC from bone marrow (BM). Coating pre-treatments were optimized for maximum cell adhesion and mineralization, while a PRP-based gel carrier was created to efficiently deliver and retain MSC and microparticles within a porous scaffold while simultaneously promoting cell recruitment, proliferation, and angiogenesis. Components and composite sponges were evaluated for osteogenic differentiation in vitro. Osteogenic sponges were loaded with MSC, PRP, PA, and NSE and implanted subcutaneously in rats to evaluate the formation of bone tissue and angiogenesis in vivo. It was found that the combination of a collagen sponge with CB MSC, PRP, PA, and the BMP2-releasing NSE formed the most bone and was most vascularized by four weeks compared to analogous composites featuring BM MSC or PCL or lacking PRP, PA, and NSE. This study indicates that CB MSC should be considered as an alternative to marrow as a source of stem cells, while the PRP-PA cell and microparticle delivery system may be utilized for diverse tissue engineering applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Supramolecular Self-Assembly in Materials · Bone Tissue Engineering Materials · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Nanomedicine and Biomedical Engineering, The Methodist Hospital Research Institute, Houston, TX 77053, USA
Centre for Stem Cell Research, The University of Texas Health Science Center at Houston, Houston, TX 77053, USA
Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX 77053, USA
Department of Materials Science and Engineering, Northwestern University, Chicago, IL 60086, USA
Department of Orthopaedics, The Methodist Hospital, Houston, TX 77053, USA
References (100+)
Show source-provided references
1. Potential role for direct gene transfer in the enhancement of fracture healing10.1097/00003086-199810001-00017 ↗
2. MDI, U.S. (2000). Markets for Biomaterials, Medical Data International, Inc.
3. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone10.1016/0142-9612(96)85762-0 ↗
4. Freed, L.E., and VunjakNovakovic, G. (2000). Principles of Tissue Engineering, Academic Press.
5. Effect of surface reaction stage on fibronectin-mediated adhesion of osteoblast-like cells to bioactive glass10.1002/(SICI)1097-4636(199804)40:1<48::AID-JBM6>3.0.CO;2-R ↗
6. Engineering three-dimensional bone tissue in vitro using biodegradable scaffolds: Investigating initial cell-seeding density and culture period10.1002/1097-4636(20000905)51:3<376::AID-JBM11>3.0.CO;2-G ↗
7. Bone formation bythree-dimensional stromal osteoblast culture in biodegradable polymer scaffolds10.1002/(SICI)1097-4636(199707)36:1<17::AID-JBM3>3.0.CO;2-O ↗
8. Engineering new bone tissue in vitro on highly porous poly(alpha-hydroxyl acids)/hydroxyapatite composite scaffolds10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W ↗
9. In vitro analysis of biodegradable polymer blend/hydroxyapatite composites for bone tissue engineering10.1002/(SICI)1097-4636(19991205)47:3<324::AID-JBM6>3.0.CO;2-Y ↗
10. Haemopoietic long-term bone marrow cultures from adult mice show osteogenic capacity in vitro on 3-dimensional collagen sponges10.1111/j.1365-2184.1992.tb01462.x ↗
11. Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation In vitro: Implications and applications for bone tissue engineering10.1007/s002230001134 ↗
12. Bone tissue engineering10.1038/nm1295-1322 ↗
13. Engineering a better way to heal broken bones
14. Chemically modified collagen: A natural biomaterial for tissue replacement10.1002/jbm.820210606 ↗
15. Three-dimensional cellular development is essential for ex vivo formation of human bone10.1038/79439 ↗
16. Tissue-engineered bone regeneration10.1038/79449 ↗
17. Use of a mineralized collagen membrane to enhance repair of calvarial defects in rats10.1111/j.1600-0501.2004.00992.x ↗
18. Scaffolds in tissue engineering bone and cartilage10.1016/S0142-9612(00)00121-6 ↗
19. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering10.1016/S0142-9612(02)00635-X ↗
20. Potential of nanofiber matrix as tissue-engineering scaffolds10.1089/ten.2005.11.101 ↗
21. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis10.1016/j.biomaterials.2004.01.066 ↗
22. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method10.1016/S0142-9612(00)00178-2 ↗
23. Development of hybrid polymer scaffolds for potential applications in ligament and tendon tissue engineering10.1088/1748-6041/2/3/001 ↗
24. Comparison of plga, pcl, and chitosan in salivary gland branching morphogenesis10.4015/S1016237208000908 ↗
25. The relationship between the mechanical properties and cell behaviour on PLGA and PCL scaffolds for bladder tissue engineering10.1016/j.biomaterials.2008.11.033 ↗
26. Experimental and computational characterization of designed and fabricated 50:50 PLGA porous scaffolds for human trabecular bone applications
27. The mesengenic process10.1016/S0094-1298(20)31020-8 ↗
28. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies10.1038/sj.leu.2400922 ↗
29. A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells10.1089/scd.2007.0069 ↗
30. The Stro-1(+) Fraction of Adult Human Bone-Marrow Contains the Osteogenic Precursors10.1182/blood.V84.12.4164.bloodjournal84124164 ↗
31. The growth-factor requirements of stro-1-positive human bone-marrow stromal precursors under serum-deprived conditions in-vitro10.1182/blood.V85.4.929.bloodjournal854929 ↗
32. Integrin-mediated interactions between human bone marrow stromal precursor cells and the extracellular matrix10.1016/S8756-3282(00)00424-5 ↗
33. Integrin expression and function on human osteoblast-like cells10.1359/jbmr.1997.12.8.1189 ↗
34. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow10.1242/jcs.00369 ↗
35. Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression10.1074/jbc.M609629200 ↗
36. G-CSF potently inhibits osteoblast activity and CXCL12 mRNA expression in the bone marrow10.1182/blood-2004-01-0272 ↗
37. Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-110.1182/blood.V78.1.55.55 ↗
38. Mesenchymal stem cells: Revisiting history, concepts, and assays10.1016/j.stem.2008.03.002 ↗
39. Mesenchymal stem cells10.1002/jor.1100090504 ↗
40. Fibroblast precursors in normal and irradiated mouse hematopoietic organs
41. Multilineage potential of adult human mesenchymal stem cells10.1126/science.284.5411.143 ↗
42. Regulation of osteogenic differentiation during skeletal development10.2741/2819 ↗
43. Mechanisms of action of demineralized bone matrix in the repair of cortical bone defects10.1097/00003086-200506000-00012 ↗
44. Role of vessels and perivascular tissue in matrix induced osteogenesis
45. The significance of angiogenesis in guided bone regeneration-A case report of a rabbit experiment10.1034/j.1600-0501.1997.080311.x ↗
46. Preliminary separation of the growth factors in platelet-rich plasma: Effects on the proliferation of human marrow-derived mesenchymal stem cells
47. The effect of platelet-rich plasma on healing in critical-size long-bone defects10.1016/j.biomaterials.2008.06.014 ↗
48. Platelet-rich plasma induces mRNA expression of VEGF and PDGF in rat bone marrow stromal cell differentiation10.1016/j.tripleo.2008.06.023 ↗
49. Platelet-rich plasma: Quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells10.1089/ten.2006.12.3067 ↗
50. The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities10.1634/stemcells.2007-0054 ↗
51. Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury10.1634/stemcells.22-3-415 ↗
52. Murine mesenchymal stem cells exhibit a restricted repertoire of functional chemokine receptors: Comparison with human10.1371/journal.pone.0002934 ↗
53. Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: Roles of phosphoinositide-3 kinase and protein kinase C10.1182/blood.V95.8.2505 ↗
54. Platelet-rich plasma: Current concepts and application in sports medicine10.5435/00124635-200910000-00002 ↗
55. Angiogenic factor-enriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material10.4047/jap.2010.2.1.7 ↗
56. Self-assembling peptide nanofiber scaffolds, platelet-rich plasma, and mesenchymal stem cells for injectable bone regeneration with tissue engineering10.1097/SCS.0b013e3181b09b7e ↗
57. Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold10.1016/j.biomaterials.2005.10.039 ↗
58. Simsek, S.B., Keles, G.C., Baris, S., and Cetinkaya, B.O. (2010). Comparison of mesenchymal stem cells and autogenous cortical bone graft in the treatment of class II furcation defects in dogs. Clin. Oral Investig.10.1007/s00784-010-0486-7 ↗
59. Modern bone regeneration instead of bone transplantation: A combination of recombinant human bone morphogenetic protein-2 and platelet-rich plasma for the vertical augmentation of the maxillary bone-a single case report10.1089/ten.tec.2010.0020 ↗
60. Intermolecular forces in the self-assembly of peptide amphiphilic nanofibers10.1002/adfm.200500161 ↗
61. Coassembly of amphiphiles with opposite peptide polarities into nanofibers10.1021/ja044863u ↗
62. Aqueous self-assembly of unsymmetric peptide amphiphiles into nanofibers with hydrophilic cores and surfaces10.1021/ja035882r ↗
63. Self-assembly and mineralization of peptide-amphiphile nanofibers10.1126/science.1063187 ↗
64. Peptide-amphiphile nanofibers: A versatile scaffold for the preparation of self-assembling materials10.1073/pnas.072699999 ↗
65. Nitric oxide and nanotechnology: A novel approach to inhibit neointimal hyperplasia10.1016/j.jvs.2007.09.005 ↗
66. Heparin binding nanostructures to promote growth of blood vessels10.1021/nl0613555 ↗
67. Hybrid bone implants: Self-assembly of peptide amphiphile nanofibers within porous titanium10.1016/j.biomaterials.2007.09.012 ↗
68. Selective differentiation of neural progenitor cells by high-epitope density nanofibers10.1126/science.1093783 ↗
69. Self-assembling nanofibers inhibit glial scar formation and promote axon elongation after spinal cord injury10.1523/JNEUROSCI.0143-08.2008 ↗
70. Coassembly of amphiphiles with opposite peptide polarities into nanofibers10.1021/ja044863u ↗
71. Self-assembled peptide amphiphile nanofibers conjugated to MRI contrast agents10.1021/nl0484898 ↗
72. Self-assembly combining two bioactive peptide-amphiphile molecules into nanofibers by electrostatic attraction10.1021/ja028215r ↗
73. Presentation and recognition of biotin on nanofibers formed by branched peptide amphiphiles10.1021/nl048238z ↗
74. Hybrid bone implants: Self-assembly of peptide amphiphile nanofibers within porous titanium10.1016/j.biomaterials.2007.09.012 ↗
75. Semiconductor-encapsulated peptide-amphiphile nanofibers10.1021/ja0499344 ↗
76. The mechanisms of oxidative-degradation of biomedical polymers by free-radicals10.1002/app.1994.070510805 ↗
77. Peptide amphiphile nanofibers with conjugated polydiacetylene backbones in their core10.1021/ja076553s ↗
78. Cancer nanotechnology: Opportunities and challenges10.1038/nrc1566 ↗
79. Nanogeometry: Beyond drug delivery10.1038/nnano.2008.46 ↗
80. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications10.1038/nnano.2008.34 ↗
81. Bioactive silicon structure fabrication through nanoetching techniques10.1002/adma.19950071215 ↗
82. The Effects of DC electric currents on the in-vitro calcification of bioactive silicon wafers10.1002/adma.19960081019 ↗
83. Derivatized mesoporous silicon with dramatically improved stability in simulated human blood plasma10.1002/(SICI)1521-4095(199912)11:18<1505::AID-ADMA1505>3.0.CO;2-C ↗
84. Porous silicon as a cell interface for bone tissue engineering10.1002/pssa.200674377 ↗
85. Evaluation of mammalian cell adhesion on surface-modified porous silicon10.1016/j.biomaterials.2006.04.015 ↗
86. Silica-based bioactive glasses modulate expression of bone morphogenetic protein-2 mRNA in Saos-2 osteoblasts in vitro10.1016/S0142-9612(00)00288-X ↗
87. Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function10.1016/S0142-9612(99)00181-7 ↗
88. Multiscale modeling of protein transport in silicon membrane nanochannels. Part 2. From molecular parameters to a predictive continuum diffusion model10.1007/s10544-006-0032-1 ↗
89. Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-210.1016/j.biomaterials.2006.09.004 ↗
90. Proteins and cells on PEG immobilized silicon surfaces10.1016/S0142-9612(98)00026-X ↗
91. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: Tissue-engineered bone regeneration10.1089/1076327041348284 ↗
92. In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination10.1002/jor.20112 ↗
93. PRP modulates expression of bone matrix proteins in vivo without long-term effects on bone formation10.1016/j.bone.2005.06.020 ↗
94. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein10.1016/S0142-9612(03)00337-5 ↗
95. BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model10.1016/j.bone.2005.02.005 ↗
96. Ectopic bone formation associated with recombinant human bone morphogenetic proteins-2 using absorbable collagen sponge and beta tricalcium phosphate as carriers10.1016/j.biomaterials.2004.07.015 ↗
97. Influence of platelet-rich plasma on osteogenic differentiation of mesenchymal stem cells and ectopic bone formation in calcium phosphate ceramics10.1159/000095511 ↗
98. Osteopontin facilitates angiogenesis, accumulation of osteoclasts, and resorption in ectopic bone10.1210/endo.142.3.8006 ↗
99. The influence of alendronate on bone formation and resorption in a rat ectopic bone development model10.1902/jop.2003.74.1.44 ↗
100. Cross-species comparison of ectopic bone formation in biphasic calcium phosphate (BCP) and hydroxyapatite (HA) scaffolds10.1089/ten.2006.12.1607 ↗